Inhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitrates

Journal of Medicinal Chemistry

Volumn 54, Issue 7, 2011, Pages 2293-2306

  Schiefer, Isaac T ^a   Abdul Hay, Samer ^a   Wang, Huali ^a   Vanni, Michael ^a   Qin, Zhihui ^a   Thatcher, Gregory R J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CHF 5074; FLURBIPROFEN; FLURBIPROFEN DERIVATIVE; INDOMETACIN; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ESTERIFICATION; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN;

AMYLOID BETA-PEPTIDES; AMYLOIDOSIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; HUMANS; MICE; NEURONS; NITRATES; SMALL MOLECULE LIBRARIES;

EID: 79953792960     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101450p     Document Type: Article

References (47)

1. Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer's disease Lancet 2006, 368, 387-403
2. Lee, V. M.; Trojanowski, J. Q. The disordered neuronal cytoskeleton in Alzheimer's disease Curr. Opin. Neurobiol. 1992, 2, 653-656
3. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002, 297, 353-356 (Pubitemid 34790756)
4. Weggen, S.; Eriksen, J. L.; Das, P.; Sagi, S. A.; Wang, R.; Pietrzik, C. U.; Findlay, K. A.; Smith, T. E.; Murphy, M. P.; Bulter, T.; Kang, D. E.; Marquez-Sterling, N.; Golde, T. E.; Koo, E. H. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity Nature 2001, 414, 212-216 (Pubitemid 33051236)
5. Findeis, M. A. The role of amyloid beta peptide 42 in Alzheimer's disease Pharmacol. Ther. 2007, 116, 266-286 (Pubitemid 47451506)
6. Reinhard, C.; Hebert, S. S.; De Strooper, B. The amyloid-beta precursor protein: integrating structure with biological function EMBO J. 2005, 24, 3996-4006 (Pubitemid 41752869)
7. Eriksen, J. L.; Sagi, S. A.; Smith, T. E.; Weggen, S.; Das, P.; McLendon, D. C.; Ozols, V. V.; Jessing, K. W.; Zavitz, K. H.; Koo, E. H.; Golde, T. E. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo J. Clin. Invest. 2003, 112, 440-449 (Pubitemid 38063773)
8. Narlawar, R.; Perez Revuelta, B. I.; Haass, C.; Steiner, H.; Schmidt, B.; Baumann, K. Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer gamma-secretase modulators J. Med. Chem. 2006, 49, 7588-7591 (Pubitemid 46033648)
9. Imbimbo, B. P.; Del Giudice, E.; Colavito, D.; D'Arrigo, A.; Dalle Carbonare, M.; Villetti, G.; Facchinetti, F.; Volta, R.; Pietrini, V.; Baroc, M. F.; Serneels, L.; De Strooper, B.; Leon, A. 1-(3′,4-Dichloro-2-fluoro[1, 1-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity J. Pharmacol. Exp. Ther. 2007, 323, 822-830 (Pubitemid 350146064)
10. Stock, N.; Munoz, B.; Wrigley, J. D.; Shearman, M. S.; Beher, D.; Peachey, J.; Williamson, T. L.; Bain, G.; Chen, W.; Jiang, X.; St-Jacques, R.; Prasit, P. The geminal dimethyl analogue of Flurbiprofen as a novel Abeta42 inhibitor and potential Alzheimer's disease modifying agent Bioorg. Med. Chem. Lett. 2006, 16, 2219-2223 (Pubitemid 43351082)
11. Peretto, I.; Radaelli, S.; Parini, C.; Zandi, M.; Raveglia, L. F.; Dondio, G.; Fontanella, L.; Misiano, P.; Bigogno, C.; Rizzi, A.; Riccardi, B.; Biscaioli, M.; Marchetti, S.; Puccini, P.; Catinella, S.; Rondelli, I.; Cenacchi, V.; Bolzoni, P. T.; Caruso, P.; Villetti, G.; Facchinetti, F.; Del Giudice, E.; Moretto, N.; Imbimbo, B. P. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(B)(42) secretion J. Med. Chem. 2005, 48, 5705-5720 (Pubitemid 41298345)
12. Sastre, M.; Dewachter, I.; Landreth, G. E.; Willson, T. M.; Klockgether, T.; van Leuven, F.; Heneka, M. T. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase J. Neurosci. 2003, 23, 9796-9804 (Pubitemid 37371592)
13. Sastre, M.; Dewachter, I.; Rossner, S.; Bogdanovic, N.; Rosen, E.; Borghgraef, P.; Evert, B. O.; Dumitrescu-Ozimek, L.; Thal, D. R.; Landreth, G.; Walter, J.; Klockgether, T.; van Leuven, F.; Heneka, M. T. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma Proc. Natl. Acad. Sci. U.S.A 2006, 103, 443-448 (Pubitemid 43122420)
14. Zhou, Y.; Su, Y.; Li, B.; Liu, F.; Ryder, J. W.; Wu, X.; Gonzalez-DeWhitt, P. A.; Gelfanova, V.; Hale, J. E.; May, P. C.; Paul, S. M.; Ni, B. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho Science 2003, 302, 1215-1217 (Pubitemid 37421027)
15. Miller, S. R.; Sekijima, Y.; Kelly, J. W. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants Lab. Invest. 2004, 84, 545-552 (Pubitemid 38858463)
16. Abdul-Hay, S. O.; Edirisinghe, P.; Thatcher, G. R. Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels J. Neurochem. 2009, 111, 683-695
17. De Strooper, B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process Physiol. Rev. 2010, 90, 465-494
18. Chow, V. W.; Mattson, M. P.; Wong, P. C.; Gleichmann, M. An overview of APP processing enzymes and products Neuromol. Med. 2010, 12, 1-12
19. Rich, J. B.; Rasmusson, D. X.; Folstein, M. F.; Carson, K. A.; Kawas, C.; Brandt, J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease Neurology 1995, 45, 51-55
20. Stewart, W. F.; Kawas, C.; Corrada, M.; Metter, E. J. Risk of Alzheimer's disease and duration of NSAID use Neurology 1997, 48, 626-632 (Pubitemid 27120096)
21. in t' Veld, B. A.; Ruitenberg, A.; Hofman, A.; Launer, L. J.; van Duijn, C. M.; Stijnen, T.; Breteler, M. M.; Stricker, B. H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease N. Engl. J. Med. 2001, 345, 1515-1521 (Pubitemid 33144916)
22. Wilcock, G. K.; Black, S. E.; Hendrix, S. B.; Zavitz, K. H.; Swabb, E. A.; Laughlin, M. A. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial Lancet Neurol. 2008, 7, 483-493
23. Marder, K. Tarenflurbil in patients with mild Alzheimer's disease Curr. Neurol. Neurosci. Rep. 2010, 10, 336-337
24. Imbimbo, B. P.; Giardino, L.; Sivilia, S.; Giuliani, A.; Gusciglio, M.; Pietrini, V.; Del Giudice, E.; D'Arrigo, A.; Leon, A.; Villetti, G.; Calza, L. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease J. Alzheimer's Dis. 2010, 20, 159-173
25. MacNaughton, W. K.; Cirino, G.; Wallace, J. L. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach Life Sci. 1989, 45, 1869-1876 (Pubitemid 19284677)
26. Chiroli, V.; Benedini, F.; Ongini, E.; Del Soldato, P. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin Eur. J. Med. Chem. 2003, 38, 441-446 (Pubitemid 36577196)
27. van Groen, T.; Kadish, I. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology Brain Res. Brain Res. Rev. 2005, 48, 370-378 (Pubitemid 40585768)
28. Abdul-Hay, S. O.; Luo, J.; Ashghodom, R. T.; Thatcher, G. R. NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade J. Neurochem. 2009, 111, 766-776
29. Prosperi, C.; Scali, C.; Barba, M.; Bellucci, A.; Giovannini, M. G.; Pepeu, G.; Casamenti, F. Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat Int. J. Immunopathol. Pharmacol. 2004, 17, 317-330 (Pubitemid 39481675)
30. Imbimbo, B. P.; Del Giudice, E.; Cenacchi, V.; Volta, R.; Villetti, G.; Facchinetti, F.; Riccardi, B.; Puccini, P.; Moretto, N.; Grassi, F.; Ottonello, S.; Leon, A. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents Pharmacol. Res. 2007, 55, 318-328 (Pubitemid 46533934)
31. Hagos, G. K.; Abdul-Hay, S. O.; Sohn, J.; Edirisinghe, P. D.; Chandrasena, R. E.; Wang, Z.; Li, Q.; Thatcher, G. R. J. Anti-inflammatory, antiproliferative, and cytoprotective activity of NO chimera nitrates of use in cancer chemoprevention Mol. Pharmacol. 2008, 74, 1381-1391
32. Hinz, B.; Brune, K.; Rau, T.; Pahl, A. Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages Pharm. Res. 2001, 18, 151-156 (Pubitemid 32592593)
33. Tegeder, I.; Niederberger, E.; Israr, E.; Guhring, H.; Brune, K.; Euchenhofer, C.; Grosch, S.; Geisslinger, G. Inhibition of NF-kappaB and AP-1 activation by R-and S -flurbiprofen FASEB J 2001, 15, 2-4
34. Thatcher, G. R. J.; Nicolescu, A. C.; Bennett, B. M.; Toader, V. Nitrates and NO release: contemporary aspects in biological and medicinal chemistry Free Radical Biol. Med. 2004, 37, 1122-1143 (Pubitemid 39302540)
35. Gasparini, L.; Rusconi, L.; Xu, H.; del Soldato, P.; Ongini, E. Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures J. Neurochem. 2004, 88, 337-348 (Pubitemid 38084550)
36. Imbimbo, B.; Hutter-Paier, B.; Villetti, G.; Facchinetti, F.; Cenacchi, V.; Volta, R.; Lanzillotta, A.; Pizzi, M.; Windisch, M. CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease Br. J. Pharmacol. 2009, 156 (6) 982-993
37. Idris, A. I.; Ralston, S. H.; van't Hof, R. J. The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action Eur. J. Pharmacol. 2009, 602, 215-222
38. Wallace, J. L.; Muscara, M. N.; de Nucci, G.; Zamuner, S.; Cirino, G.; del Soldato, P.; Ongini, E. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1-biphenyl]-4-acetyloxy)-3- methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester] J. Pharmacol. Exp. Ther. 2004, 309, 626-633 (Pubitemid 38542616)
39. Govoni, M.; Casagrande, S.; Maucci, R.; Chiroli, V.; Tocchetti, P. In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate J. Pharmacol. Exp. Ther. 2006, 317, 752-761
40. Prosperi, C.; Scali, C.; Pepeu, G.; Casamenti, F. NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain Jpn J. Pharmacol. 2001, 86, 230-235
41. Kukar, T.; Murphy, M. P.; Eriksen, J. L.; Sagi, S. A.; Weggen, S.; Smith, T. E.; Ladd, T.; Khan, M. A.; Kache, R.; Beard, J.; Dodson, M.; Merit, S.; Ozols, V. V.; Anastasiadis, P. Z.; Das, P.; Fauq, A.; Koo, E. H.; Golde, T. E. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production Nature Med. 2005, 11, 545-550 (Pubitemid 40685978)
42. Kukar, T. L.; Ladd, T. B.; Bann, M. A.; Fraering, P. C.; Narlawar, R.; Maharvi, G. M.; Healy, B.; Chapman, R.; Welzel, A. T.; Price, R. W.; Moore, B.; Rangachari, V.; Cusack, B.; Eriksen, J.; Jansen-West, K.; Verbeeck, C.; Yager, D.; Eckman, C.; Ye, W.; Sagi, S.; Cottrell, B. A.; Torpey, J.; Rosenberry, T. L.; Fauq, A.; Wolfe, M. S.; Schmidt, B.; Walsh, D. M.; Koo, E. H.; Golde, T. E. Substrate-targeting gamma-secretase modulators Nature 2008, 453, 925-929
43. Page, R. M.; Baumann, K.; Tomioka, M.; Perez-Revuelta, B. I.; Fukumori, A.; Jacobsen, H.; Flohr, A.; Luebbers, T.; Ozmen, L.; Steiner, H.; Haass, C. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation J. Biol. Chem. 2008, 283, 677-683
44. Takahashi, Y.; Hayashi, I.; Tominari, Y.; Rikimaru, K.; Morohashi, Y.; Kan, T.; Natsugari, H.; Fukuyama, T.; Tomita, T.; Iwatsubo, T. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation J. Biol. Chem. 2003, 278, 18664-18670 (Pubitemid 36799494)
45. Peretto, I.; Radaelli, S.; Parini, C.; Zandi, M.; Raveglia, L. F.; Dondio, G.; Fontanella, L.; Misiano, P.; Bigogno, C.; Rizzi, A.; Riccardi, B.; Biscaioli, M.; Marchetti, S.; Puccini, P.; Catinella, S.; Rondelli, I.; Cenacchi, V.; Bolzoni, P. T.; Caruso, P.; Villetti, G.; Facchinetti, F.; DelGiudice, E.; Moretto, N.; Imbimbo, B. P. Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid1-42 secretion J. Med. Chem. 2005, 48, 5705-5720 (Pubitemid 41298345)
46. Kotoris, C. C.; Chen, M.-J.; Taylor, S. D. Preparation of benzylic I±-difluoronitriles, -tetrazoles, and -sulfonates via electrophilic fluorination J. Org. Chem. 1998, 63, 8052-8057 (Pubitemid 128723057)
47. Zhang, F.; Song, J. Z. A novel general method for preparation of [alpha]-fluoro-[alpha]-arylcarboxylic acid. Direct fluorination of silyl ketene acetals with Selectfluor Tetrahedron Lett. 2006, 47, 7641-7644 (Pubitemid 44402529)